NASDAQ OMX

GetYourGuide Raises $75 Million To Expand Global Marketplace for Travel Activities

Dela

Global technology investment firm Battery Ventures leads Series D funding round; General Partner Itzik Parnafes joins GetYourGuide Board of Directors

BERLIN, Nov. 02, 2017 (GLOBE NEWSWIRE) -- GetYourGuide, the largest online booking platform for travel activities, today announced it has closed a $75 million Series D funding round led by Battery Ventures, a global technology-focused investment firm. Battery Ventures is joined in the funding round by all of GetYourGuide's existing venture partners, including KKR, Spark Capital, Highland Europe, Sunstone Capital and Nokia Growth Partners (NGP). The new capital will be applied toward international expansion and technological development as GetYourGuide strengthens its position as the global market leader for tours, activities and attractions.

The funding comes at a time of unprecedented momentum for GetYourGuide, which this summer crossed the threshold of 10 million tickets booked, with nearly half of those booked in 2017 alone. The in-destination activities segment of the global tourism industry, which now represents a $135 billion market and accounts for 10 percent of global leisure travel revenue, is growing at a similar clip: recent estimates project that the global market for tours and activities will reach $183 billion by 2020, and that online bookings within the segment will more than double from 2015 levels. 1

"We are experiencing explosive growth this year and have stepped up to become the largest online booking platform for travel activities," said Johannes Reck, CEO of GetYourGuide. "It's our goal to significantly disrupt the in-destination travel experience in the years ahead, and the financing we've raised from both new and existing investors represents a vote of confidence in our progress toward capturing the massive market opportunity before us."

As part of Battery Ventures' lead investment in the funding round, GetYourGuide's Board of Directors has been strengthened with the addition of General Partner Itzik Parnafes. An Israeli-born entrepreneur and investor, Parnafes brings a decade of experience in advising technology-focused businesses across a diverse array of industries.

"The company has already made significant progress in carving out a large and high-profile niche in the European travel market," said Parnafes. "I'm looking forward to working closely with the Board to support its efforts to capitalize on what I think is a very exciting segment of global tourism."

GetYourGuide is the latest addition to Battery's portfolio of travel software, experience and marketplace companies, which it has built over the past decade and a half across the U.S. and Europe.

About GetYourGuide

As the largest online booking platform for travel activities, GetYourGuide powers access to more than 31,000 tours, activities and attractions in upwards of 7,300 destinations around the world. From Skip-the-Line tickets to the Eiffel Tower to shark diving in Cape Town, GetYourGuide offers things to do for every traveller, both on its own site and in partnership with premier travel brands worldwide. Headquartered in Berlin, GetYourGuide employs more than 400 people across its offices in 11 countries. For additional information about GetYourGuide, please visit the company's website at www.getyourguide.com.

About Battery Ventures

Battery strives to invest in cutting-edge, category-defining businesses in markets including software and services, Web infrastructure, consumer Internet, mobile and industrial technologies. Founded in 1983, the firm backs companies at stages ranging from seed to private equity and invests globally from offices in Boston, the San Francisco Bay Area, Tel Aviv and London. Follow the firm on Twitter @BatteryVentures, visit www.battery.com and find a full list of Battery's portfolio companies here.

Press Contact

Will Gluckin

GetYourGuide

+49 176 7112 0875

will.gluckin@getyourguide.com

____________________________________

1 Source: Phocuswright, "Tours & Activities Come of Age: The Global Travel Activities Marketplace 2014-2020" 2017




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Battery Ventures via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

VistaJet Partners With Christie's for the Global Tour of The Collection of Peggy and David Rockefeller22.11.2017 11:39Pressmeddelande

The sale will be the most significant philanthropic auction ever presented LONDON, Nov. 22, 2017 (GLOBE NEWSWIRE) -- VistaJet, the first and only global private aviation company, announces today its worldwide sponsorship of the exhibition and tour of The Collection of Peggy and David Rockefeller, the most significant auction entirely dedicated to raising funds for philanthropic causes.  The sale, consisting of numerous categories, will be conducted by Christie's, the world's leading art business, and will include a highlights exhibition tour in Hong Kong, London, Los Angeles and New York. Photos accompanying this announcement are available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c78fdce7-7651-42a8-a621-14088da2cc86 http://www.globenewswire.com/NewsRoom/AttachmentNg/33af2489-a9a8-4bbe-b5f7-78e4c1f29ca2 http://www.globenewswire.com/NewsRoom/AttachmentNg/a16c2

Nasdaq to Deliver Blockchain e-Voting Solution to Strate22.11.2017 10:00Pressmeddelande

South Africa's central securities depository (CSD) will leverage the solution to improve voting efficiencies and increase shareholder participation in South Africa STOCKHOLM, Sweden and JOHANNESBURG, South Africa, Nov.  22, 2017  (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) and Strate (Pty) Ltd, the South African CSD, announced today an agreement for Nasdaq to deliver a new blockchain solution that would bring electronic voting to the South African capital markets. The solution will allow Strate, in conjunction with key stakeholders in the market, to provide general meeting services and give shareholders an easy, user-friendly and secure tool for voting remotely. The solution is based on the successful proof of concept (PoC) developed for Nasdaq's Estonia market. In addition, Strate will contribute to the ongoing market development of e-Voting technology. "We are very excited about our initiative with Nasdaq and what it means for the South African financial markets," said Tan

Immunicum AB: Invitation to Investor Events22.11.2017 08:00Pressmeddelande

Press release November 22, 2017 Invitation to Investor Events Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment against a variety of solid tumors, today announced that CEO Carlos de Sousa will present the Company as well as provide background on the previously announced proposed Rights Issue at two upcoming investor events. Aktiespararna Stora Aktiedagen in Gothenburg Date: Monday, November 27, 2017 Presentation Time: 10:10-10:40 CET Location: Svenska Mässan, Mässans Gata 8, Gothenburg Please register to attend at https://www.aktiespararna.se/aktiviteter/stora-aktiedagen-goteborg. Immunicum Investor Event in Stockholm Date: Thursday, November 30, 2017 Presentation Time: 18:00-19:00 CET Location: United Spaces, Waterfront Building, Floor 2, Klarabergsviadukt

Immunicum AB: Inbjudan till investerarmöten22.11.2017 08:00Pressmeddelande

Pressmeddelande 22 november 2017 Inbjudan till investerarmöten Immunicum AB (publ), First North Premier: (IMMU.ST), ett bioteknikbolag som utvecklar nya immunaktiverande cancerbehandlingar för ett antal solida tumörer, meddelar dag att VD Carlos de Sousa kommer att presentera bolaget samt bakgrunden till bolagets föreslagna nyemission vid två kommande investerarmöten. Stora Aktiedagen i Göteborg, Aktiespararna Datum: Måndagen den 27 november, 2017 Plats: Svenska Mässan, Mässans gata 8, Göteborg Tid: Kl 10.10 - 10.40 i sal 4 Vänligen anmäl deltagande via https://www.aktiespararna.se/aktiviteter/stora-aktiedagen-goteborg. Immunicums investerarmöte i Stockholm Tid: Kl. 18.00 torsdagen 30 november 2017 Plats: United Spaces, Waterfront, Klarabergsviadukten 63 plan 2, Stockholm Det bjuds på lättare förtäring och dryck efter presentationen.

Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference21.11.2017 15:15Pressmeddelande

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that Peter Wrighton-Smith, Chief Executive Officer, will present at the 29th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28th, at 12:00 p.m. EST. The conference will be held at the Lotte New York Palace. A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.oxfordimmunotec.com. A webcast replay will be available approximately two hours after the live presentation and will be archived on the website for approximately 90 days. About Oxford Immunotec Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and comme

CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs21.11.2017 14:00Pressmeddelande

SANTA CLARA, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the publication of two new papers. These joint publications illustrate the utility of Crown Bioscience's proprietary FATZO model as a model for obesity and type 2 diabetes in preclinical studies. The research conducted by Crown Bioscience, Eli Lilly and Company and Ball State University was published in two PLOS ONE papers: Peterson et al. Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco model PLOS One 2017;12 (6):e0179856, https://doi.org/10.1371/journal.pone.0179856  Droz et al. Correlation of disease severity with body weight and high fat diet in the FATZO/Pco model PLOS One 2017;1

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum